help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

Published ahead of print on June 23, 2004, doi:10.1164/rccm.200402-162OC

Am. J. Respir. Crit. Care Med., Volume 170, Number 7, October 2004, 793-798

A more recent version of this article appeared on October 1, 2004
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
200402-162OCv1
170/7/793    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Marras, T. K
Right arrow Articles by Daley, C. L
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Marras, T. K
Right arrow Articles by Daley, C. L

Submitted on February 10, 2004
Accepted on June 22, 2004

Mortality Prediction in Pulmonary Mycobacterium kansasii Infection and Human Immunodeficiency Virus

Theodore K Marras1*, Alison Morris2, Leah C Gonzalez3, and Charles L Daley3

1 Department of Medicine and Respirology, University of Toronto, Toronto, ON, Canada, 2 Department of Medicine and Pulmonary and Critical Care, University of Southern California, Los Angeles, CA, USA, 3 Department of Medicine, University of California, San Francisco, San Francisco, CA, USA

* To whom correspondence should be addressed. E-mail: ted.marras{at}utoronto.ca.

In the setting of human immunodeficiency virus (HIV) infection, the clinical implications of American Thoracic Society (ATS) diagnostic criteria and the significance of a single positive respiratory culture for Mycobacterium kansasii are unknown. We retrospectively studied HIV-infected patients with pulmonary M. kansasii isolated between 1989 and 2002 at one institution. Of 127 patients, 33% fulfilled ATS disease criteria, 29% received at least 3 active drugs for at least 3 months, and 53% died. In survival analysis, lower CD4 count (HR [95% CI] 1.6 [1.1-2.3]) and positive smear microscopy (2.8 [1.3-6.1]) were associated with mortality, while anti-retroviral therapy (0.3 [0.1-0.8]) and M. kansasii treatment (0.4 [0.2-0.9]) were associated with survival. ATS criteria did not predict mortality (0.9 [0.4-1.9]). Fifteen patients (12%) apparently had indolent infection, not requiring immediate therapy. They had fewer positive cultures and lower rates of positive smear microscopy and ATS-defined disease. In HIV-infected patients with pulmonary M. kansasii infection, predictors of survival include higher CD4 counts, anti-retroviral therapy, negative smear microscopy and adequate treatment for M. kansasii infection, but not ATS diagnostic criteria. Withholding treatment in HIV-infected patients with respiratory M. kansasii isolates should only be considered with negative smear microscopy, few positive cultures and mild immunosuppression.


Key words: Guidelines Mycobacterium infections, atypical Survival analysis




This article has been cited by other articles:


Home page
ChestHome page
A. Cattamanchi, P. Nahid, T. K. Marras, M. B. Gotway, T. J. Lee, L. C. Gonzalez, A. Morris, W. R. Webb, D. H. Osmond, and C. L. Daley
Detailed Analysis of the Radiographic Presentation of Mycobacterium kansasii Lung Disease in Patients With HIV Infection
Chest, April 1, 2008; 133(4): 875 - 880.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
S. K. Field and R. L. Cowie
Lung Disease Due to the More Common Nontuberculous Mycobacteria
Chest, June 1, 2006; 129(6): 1653 - 1672.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
B. Nemery, W. W. Yew, R. Albert, C. Brun-Buisson, W. MacNee, F. J. Martinez, D. C. Angus, and E. Abraham
Tuberculosis, Nontuberculous Lung Infection, Pleural Disorders, Pulmonary Function, Respiratory Muscles, Occupational Lung Disease, Pulmonary Infections, and Social Issues in AJRCCM in 2004
Am. J. Respir. Crit. Care Med., March 15, 2005; 171(6): 554 - 562.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2004 American Thoracic Society